1310 related articles for article (PubMed ID: 32376803)
1. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity.
Tadokoro T; Ikeda M; Ide T; Deguchi H; Ikeda S; Okabe K; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
JCI Insight; 2020 May; 5(9):. PubMed ID: 32376803
[TBL] [Abstract][Full Text] [Related]
2. MITOL/MARCH5 determines the susceptibility of cardiomyocytes to doxorubicin-induced ferroptosis by regulating GSH homeostasis.
Kitakata H; Endo J; Matsushima H; Yamamoto S; Ikura H; Hirai A; Koh S; Ichihara G; Hiraide T; Moriyama H; Shirakawa K; Goto S; Katsumata Y; Anzai A; Kataoka M; Tokuyama T; Ishido S; Yanagi S; Fukuda K; Sano M
J Mol Cell Cardiol; 2021 Dec; 161():116-129. PubMed ID: 34390730
[TBL] [Abstract][Full Text] [Related]
3. Ethoxyquin is a Competent Radical-Trapping Antioxidant for Preventing Ferroptosis in Doxorubicin Cardiotoxicity.
Tadokoro T; Ikeda M; Abe K; Ide T; Miyamoto HD; Furusawa S; Ishimaru K; Watanabe M; Ishikita A; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
J Cardiovasc Pharmacol; 2022 Nov; 80(5):690-699. PubMed ID: 35881422
[TBL] [Abstract][Full Text] [Related]
4. Protective Role of Dioscin against Doxorubicin-Induced Chronic Cardiotoxicity: Insights from Nrf2-GPX4 Axis-Mediated Cardiac Ferroptosis.
Liu J; Liu H; Deng L; Wang T; Li L; Chen Y; Qu L; Zou W
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672439
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin IV ameliorates doxorubicin-induced cardiotoxicity by increasing glutathione peroxidase 4 and alleviating ferroptosis.
Yang L; Guan J; Luo S; Yan J; Chen D; Zhang X; Zhong C; Yang P
Toxicol Appl Pharmacol; 2023 Nov; 479():116713. PubMed ID: 37838222
[TBL] [Abstract][Full Text] [Related]
6. Doxorubicin causes ferroptosis and cardiotoxicity by intercalating into mitochondrial DNA and disrupting Alas1-dependent heme synthesis.
Abe K; Ikeda M; Ide T; Tadokoro T; Miyamoto HD; Furusawa S; Tsutsui Y; Miyake R; Ishimaru K; Watanabe M; Matsushima S; Koumura T; Yamada KI; Imai H; Tsutsui H
Sci Signal; 2022 Nov; 15(758):eabn8017. PubMed ID: 36318618
[TBL] [Abstract][Full Text] [Related]
7. The Bach1/HO-1 pathway regulates oxidative stress and contributes to ferroptosis in doxorubicin-induced cardiomyopathy in H9c2 cells and mice.
Wang Y; Qiu J; Yan H; Zhang N; Gao S; Xu N; Wang C; Lou H
Arch Toxicol; 2024 Jun; 98(6):1781-1794. PubMed ID: 38573338
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis as a target for protection against cardiomyopathy.
Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide alleviates mitochondrial damage and ferroptosis by regulating OPA3-NFS1 axis in doxorubicin-induced cardiotoxicity.
Wang Y; Ying X; Wang Y; Zou Z; Yuan A; Xiao Z; Geng N; Qiao Z; Li W; Lu X; Pu J
Cell Signal; 2023 Jul; 107():110655. PubMed ID: 36924813
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Targets for DOX-Induced Cardiomyopathy: Role of Apoptosis vs. Ferroptosis.
Kitakata H; Endo J; Ikura H; Moriyama H; Shirakawa K; Katsumata Y; Sano M
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163335
[TBL] [Abstract][Full Text] [Related]
11. Melatonin alleviates doxorubicin-induced mitochondrial oxidative damage and ferroptosis in cardiomyocytes by regulating YAP expression.
Sun X; Sun P; Zhen D; Xu X; Yang L; Fu D; Wei C; Niu X; Tian J; Li H
Toxicol Appl Pharmacol; 2022 Feb; 437():115902. PubMed ID: 35093381
[TBL] [Abstract][Full Text] [Related]
12. Cardiac sirtuin1 deficiency exacerbates ferroptosis in doxorubicin-induced cardiac injury through the Nrf2/Keap1 pathway.
Wang W; Zhong X; Fang Z; Li J; Li H; Liu X; Yuan X; Huang W; Huang Z
Chem Biol Interact; 2023 May; 377():110469. PubMed ID: 37030624
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy.
Huang C; Guo Y; Li T; Sun G; Yang J; Wang Y; Xiang Y; Wang L; Jin M; Li J; Zhou Y; Han B; Huang R; Qiu J; Tan Y; Hu J; Wei Y; Wu B; Mao Y; Lei L; Song X; Li S; Wang Y; Zhang T
Redox Biol; 2024 Apr; 70():103024. PubMed ID: 38232458
[TBL] [Abstract][Full Text] [Related]
14. Exosomal thioredoxin-1 from hypoxic human umbilical cord mesenchymal stem cells inhibits ferroptosis in doxorubicin-induced cardiotoxicity via mTORC1 signaling.
Yu Y; Wu T; Lu Y; Zhao W; Zhang J; Chen Q; Ge G; Hua Y; Chen K; Ullah I; Zhang F
Free Radic Biol Med; 2022 Nov; 193(Pt 1):108-121. PubMed ID: 36241072
[TBL] [Abstract][Full Text] [Related]
15. Trastuzumab-induced cardiomyopathy via ferroptosis-mediated mitochondrial dysfunction.
Ye T; Yang W; Gao T; Yu X; Chen T; Yang Y; Guo J; Li Q; Li H; Yang L
Free Radic Biol Med; 2023 Sep; 206():143-161. PubMed ID: 37392951
[TBL] [Abstract][Full Text] [Related]
16. WGX50 mitigates doxorubicin-induced cardiotoxicity through inhibition of mitochondrial ROS and ferroptosis.
Tai P; Chen X; Jia G; Chen G; Gong L; Cheng Y; Li Z; Wang H; Chen A; Zhang G; Zhu Y; Xiao M; Wang Z; Liu Y; Shan D; He D; Li M; Zhan T; Khan A; Li X; Zeng X; Li C; Ouyang D; Ai K; Chen X; Liu D; Liu Z; Wei D; Cao K
J Transl Med; 2023 Nov; 21(1):823. PubMed ID: 37978379
[TBL] [Abstract][Full Text] [Related]
17. PRMT4 promotes ferroptosis to aggravate doxorubicin-induced cardiomyopathy via inhibition of the Nrf2/GPX4 pathway.
Wang Y; Yan S; Liu X; Deng F; Wang P; Yang L; Hu L; Huang K; He J
Cell Death Differ; 2022 Oct; 29(10):1982-1995. PubMed ID: 35383293
[TBL] [Abstract][Full Text] [Related]
18. LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
Liu X; Li D; Pi W; Wang B; Xu S; Yu L; Yao L; Sun Z; Jiang J; Mi Y
Int Immunopharmacol; 2022 Dec; 113(Pt A):109379. PubMed ID: 36330913
[TBL] [Abstract][Full Text] [Related]
19. Activation of p62-NRF2 Axis Protects against Doxorubicin-Induced Ferroptosis in Cardiomyocytes: A Novel Role and Molecular Mechanism of Resveratrol.
Yu W; Chen C; Xu C; Xie D; Wang Q; Liu W; Zhao H; He F; Chen B; Xi Y; Yan Y; Yu L; Cheng J
Am J Chin Med; 2022; 50(8):2103-2123. PubMed ID: 36309811
[TBL] [Abstract][Full Text] [Related]
20. Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis.
Liao HH; Ding W; Zhang N; Zhou ZY; Ling Z; Li WJ; Chen S; Tang QZ
Free Radic Biol Med; 2023 Aug; 205():275-290. PubMed ID: 37331642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
